Rinaldi Vittorio, Casale Manuele, Bressi Federica, Potena Massimiliano, Vesperini Emanuela, De Franco Antonio, Silvestri Sergio, Zini Carlo, Salvinelli Fabrizio
Area of Otolaryngology;
J Neurol Surg B Skull Base. 2012 Feb;73(1):21-7. doi: 10.1055/s-0032-1304559.
In this study we evaluate the postoperative facial nerve function after vestibular schwannoma (VS) surgery and analyze the factors that cause it. We included 97 consecutive patients undergoing surgical excision of sporadic unilateral VS. Patient and tumor characteristics, surgical approaches, facial nerve function, extent of tumor removal, perioperative complications are all analyzed through standardized systems. Four different surgical approaches are used: translabyrinthine, retrolabyrinthine, retrosigmoid, and middle cranial fossa. Anatomic preservation of the facial nerve is achieved in 97% of patients. The incidence of postoperative facial palsy is found to be statistically correlated to tumor size, but not to the surgical approach used and to extent of tumor penetration in the internal auditory canal. A significant improvement of the short-term facial nerve outcome is detected in patients undergone simultaneous intraoperative electromyography (EMG) and pneumatic facial nerve monitoring. Complete tumor excision is achieved in 94% of cases. Complication rates are excellent and no deaths are reported. Short- and long-term facial nerve outcome is good and comparable with those of other series reported in literature. In VS surgery both EMG and pneumatic facial nerve monitors should be simultaneously used. Further investigations are desirable to improve the facial outcome respecting the oncological radicality.
在本研究中,我们评估了前庭神经鞘瘤(VS)手术后的面神经功能,并分析了导致该功能变化的因素。我们纳入了97例连续接受散发性单侧VS手术切除的患者。通过标准化系统对患者和肿瘤特征、手术入路、面神经功能、肿瘤切除范围、围手术期并发症进行了分析。采用了四种不同的手术入路:经迷路、迷路后、乙状窦后和中颅窝。97%的患者实现了面神经的解剖学保留。发现术后面瘫的发生率与肿瘤大小在统计学上相关,但与所采用的手术入路以及肿瘤向内耳道的浸润程度无关。在术中同时进行肌电图(EMG)和气动面神经监测的患者中,短期面神经预后有显著改善。94%的病例实现了肿瘤的完全切除。并发症发生率良好,无死亡报告。短期和长期面神经预后良好,与文献报道的其他系列结果相当。在VS手术中,应同时使用EMG和气动人面神经监测仪。需要进一步研究以在尊重肿瘤根治性的同时改善面神经预后。